These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4280885)

  • 41. Suramin and eosinophil degranulation and vacuolation in onchocerciasis.
    Newsome F
    Lancet; 1987 Jun; 1(8546):1381-2. PubMed ID: 2884489
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of suramin on trypomastigote forms of Trypanosoma cruzi: changes on cell motility and on the ultrastructure of the flagellum-cell body attachment region.
    Bisaggio DF; Campanati L; Pinto RC; Souto-Padrón T
    Acta Trop; 2006 May; 98(2):162-75. PubMed ID: 16716244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The trypanocidal action of homidium, quinapyramine and suramin.
    HAWKING F; SEN AB
    Br J Pharmacol Chemother; 1960 Dec; 15(4):567-70. PubMed ID: 13712404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Observations on levels of immunoglobulin M in confirmed cases of Trypanosoma rhodesiense infection in the Lambwe Valley.
    Binz G
    Bull World Health Organ; 1972; 47(6):751-5. PubMed ID: 4544826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A STUDY OF GRANULES AND OTHER CHANGES IN PHASE-CONTRAST APPEARANCE PRODUCED BY CHEMOTHERAPEUTIC AGENTS IN TRYPANOSOMES.
    ORMEROD WE; SHAW JJ
    Br J Pharmacol Chemother; 1963 Oct; 21(2):259-72. PubMed ID: 14081657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of calcitonin on fibroblasts and collagen formation in rabbits: an ultrastructural and scanning electron microscopic study.
    Lupulescu A
    J Morphol; 1974 Apr; 142(4):447-63. PubMed ID: 4824674
    [No Abstract]   [Full Text] [Related]  

  • 47. The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site.
    Morgan HP; McNae IW; Nowicki MW; Zhong W; Michels PA; Auld DS; Fothergill-Gilmore LA; Walkinshaw MD
    J Biol Chem; 2011 Sep; 286(36):31232-40. PubMed ID: 21733839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of cobaltous chloride in laboratory animals. I. The histological and electron microscopical changes in the islets of rabbits.
    Telib M
    Endokrinologie; 1972 Jun; 60(1):81-102. PubMed ID: 4117146
    [No Abstract]   [Full Text] [Related]  

  • 49. [Abortifacient and teratogenic effect of suramin, a trypanocide].
    Mercier-Parot L; Tuchmann-Duplessis H
    C R Seances Soc Biol Fil; 1973; 167(11):1518-22. PubMed ID: 4803127
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug resistance in trapanososmes: cross-resitance analyses.
    WILLIAMSON J; ROLLO IM
    Br J Pharmacol Chemother; 1959 Dec; 14(4):423-30. PubMed ID: 13844958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nerolidol nanospheres increases its trypanocidal efficacy against Trypanosoma evansi: New approach against diminazene aceturate resistance and toxicity.
    Baldissera MD; Grando TH; Souza CF; Cossetin LF; Sagrillo MR; Nascimento K; da Silva AP; Dalla Lana DF; Da Silva AS; Stefani LM; Monteiro SG
    Exp Parasitol; 2016 Jul; 166():144-9. PubMed ID: 27109312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trypanocidal activity of a new series of arsenical compounds the spiroarsorans.
    Loiseau P; Bories C; Gayral P; Wolf JG
    Farmaco Sci; 1988; 43(7-8):657-63. PubMed ID: 3224710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fast, simple, and low-cost test for drug-resistant pathogens.
    te Pas MF; Claes F; Büscher P
    Lancet; 2005 Aug 6-12; 366(9484):437-8. PubMed ID: 16084237
    [No Abstract]   [Full Text] [Related]  

  • 54. An assay for screening drugs against animal-infective bloodstream forms of Trypanosoma brucei brucei in vitro.
    Borowy NK; Hirumi H; Waithaka HK; Mkoji G
    Drugs Exp Clin Res; 1985; 11(3):155-61. PubMed ID: 3836123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug synergy in experimental African trypanosomiasis.
    Williamson J; March JC; Scott-Finnigan TJ
    Tropenmed Parasitol; 1982 Jun; 33(2):76-82. PubMed ID: 7112684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition by several standard antiprotozoal drugs of growth and O2 uptake of cells and particulate preparations of a Leptomonas.
    Goldberg B; Lambros C; Bacchi CJ; Hutner SH
    J Protozool; 1974 May; 21(2):322-6. PubMed ID: 4365631
    [No Abstract]   [Full Text] [Related]  

  • 57. Susceptibility of an insect Leptomonas and Crithidia fasciculata to several established antitrypanosomatid agents.
    Bacchi J; Lambros C; Goldberg B; Hutner SH; de Carvalho GD
    Antimicrob Agents Chemother; 1974 Dec; 6(6):785-90. PubMed ID: 4451351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental induction of suramin-resistance in cloned and uncloned stocks of Trypanosoma evansi using immunosuppressed and immunocompetent mice.
    Mutugi MW; Boid R; Luckins AG
    Trop Med Parasitol; 1994 Sep; 45(3):232-6. PubMed ID: 7899794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Modification of epidermal differentiation by vitamin A acid. Electron microscopy study].
    Wolff HH; Christophers E; Braun-Falco O
    Arch Klin Exp Dermatol; 1970; 237(3):774-95. PubMed ID: 5523570
    [No Abstract]   [Full Text] [Related]  

  • 60. Spiroarsoranes of second generation: evaluation of trypanocidal properties against Trypanosoma brucei brucei.
    Loiseau PM; Wolf JG; Gayral P
    Trop Med Parasitol; 1993 Mar; 44(1):32-6. PubMed ID: 8516630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.